Skip links

Emmanuel Egbogah Foundation Contributes to the Growing Discourse on the Battle Against COVID-19 Pandemic

No description available.The Emmanuel Egbogah Foundation collaborated with PetroNet-Africa and held a webinar on June 11 titled “Drug Discovery and Development Process: Kissing Many Frogs Before Meeting the Prince” to discuss the drug discovery and development process for infectious diseases. The objective of the webinar was to contribute to the growing discussions on the  battle against the COVID-19 pandemic. The webinar was delivered by Professor Vincent Idemyor, a clinical faculty at the Faculty of Pharmaceutical Science, University of Port Harcourt. 

Professor Iyeopu Siminialayi, Provost College of Health Science at the University of Port Harcourt commenced the webinar by stating the lecture’s importance at this time, given the need for effective prophylactics and treatments for the SARS-CoV-2 virus that is responsible for the COVID-19 pandemic. He emphasized the relevance of this discussion for Africans, asserting that while Africans consume several herbal remedies in their crude forms, other people have developed drugs from these same crude extracts that are used worldwide.

The webinar lecturer, Professor Vincent Idemyor discussed the modern steps involved in drug discovery process and development. In his lecture, Professor Idemyor stated that in the past, many medicines were isolated traditionally from natural products. But in modern times, the drug discovery process begins with the identification of a disease. The disease model is used to pinpoint relevant drug targets. Then, the drug target is validated, identified, and optimized, with clinical trials before the drug is sent to the market. The speaker identified technology as a key factor impacting the drug discovery process, with up to 100,000 compounds being screened daily using computers making the process more efficient and less cumbersome.

Professor Idemyor emphasized that despite the impact of technology, the path to new medicine is an expensive and lengthy process involving high development cost, extensive research, and clinical testing. He projected that a typical drug development time takes an average of 10-15 years with a cost of $800million -$1.5 billion. The process is considered a marathon and not a sprint. He however, recommended important keys for  the drug discovery and development  process such as: shared science, continuous improvement, more transparency, deep scientific knowledge, and cost effectiveness balanced with ethics. The lecture was concluded with this quote “If you do not collaborate, you die”, thus emphasizing the relevance and future vision of collaboration and integration.

It is noteworthy that the webinar was well attended and very interactive.

The recordings and presentation have been posted on the media page of our website for public viewing and feedbacks. 

Join the Discussion